Evaluation of PLGA containing anti -CTLA4 inhibited endometriosis progression by regulating CD4 + CD25 + Treg cells in peritoneal fluid of mouse endometriosis model
article
OA: closed
CC0
⤵ 22 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
PLGA containing anti-CTLA4 therapy inhibited endometriosis progression in a mouse model by regulating CD4+CD25+ Treg cells in peritoneal fluid.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- A Novel Mouse Model of Endometriosis Mimics Human Phenotype and Reveals Insights into the Inflammatory Contribution of Shed Endometrium via openalex
- CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
- Emerging therapy for endometriosis via openalex
- IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors via openalex
- Interleukin-10 attenuates TNF-α–induced interleukin-6 production in endometriotic stromal cells via openalex
- Leflunomide—an Immunomodulator—Induces Regression of Endometrial Explants in a Rat Model of Endometriosis via openalex
- The Peritoneum Is Both a Source and Target of TGF-β in Women with Endometriosis via openalex
- W2004755026 via openalex
- W2015189577 via openalex
- W2016732129 via openalex
- W2020398834 via openalex
- W2022981155 via openalex
- W2049126749 via openalex
- W2065569312 via openalex
- W2074632761 via openalex
- W2080652842 via openalex
- W2092967539 via openalex
- W2100228832 via openalex
- W2101581360 via openalex
- W2105958268 via openalex
- W2107631420 via openalex
- W2118503880 via openalex
- W2120143538 via openalex
- W2122008881 via openalex
- W2130822830 via openalex
- W2133655433 via openalex
- W2134638467 via openalex
- W2139191751 via openalex
- W2145887384 via openalex
- W2218652881 via openalex
- W2320114223 via openalex
- W2346020725 via openalex
- W2347141054 via openalex
- W4211081176 via openalex
- W102419399 via openalex
- W6604208979 via openalex
- W1487731794 via openalex
- W1581904411 via openalex
- W1592696248 via openalex
- W1661347229 via openalex
- W1865915382 via openalex
- W1997750937 via openalex
Cited by (22)
- PBMC-derived FGF, PDGF, VEGF and GM-CSF secretion in endometriosis: a case–control in vitro study 2026
- Biomaterial Tools for Modeling Endometriosis 2026
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy 2024
- Immune сheckpoints in the context of external genital endometriosis 2024
- Emerging strategies for the treatment of endometriosis 2024
- The long road of drug development for endometriosis – Pains, gains, and hopes 2024
- Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis 2024
- Applications of nanomaterials in endometriosis treatment 2023
- Nanotechnologies for the detection and treatment of endometriosis 2023
- Copaiba Oilresin Exerts an Additive Effect to the Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- SCM-198 Alleviates Endometriosis by Suppressing Estrogen-ERα mediated Differentiation and Function of CD4<sup>+</sup>CD25<sup>+</sup> Regulatory T Cells 2022
- A multifunctional nanoparticle for efferocytosis and pro-resolving-mediated endometriosis therapy 2022
- Copaiba Oil Resin Exerts an Additive Effect to Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- Papel de MICA na endometriose 2022
- The Role of the Immune System in the Development of Endometriosis 2022
- Immunosuppression and immunotherapy in endometriosis 2021
- Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis 2021
- CLTA-4 Expression Is Associated with the Maintenance of Chronic Inflammation in Endometriosis and Infertility 2021
- Reduction of myeloid derived suppressor cells by inhibiting Notch pathway prevents the progression of endometriosis in mice model 2020
- Anti-inflammatory cytokines in endometriosis 2019
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:43.714878+00:00
License: CC0
· commercial use OK